Multicenter retrospective study on the use of Curebest™ 95GC Breast for estrogen receptor-positive and node-negative early breast cancer

BACKGROUND: The benefits of postoperative chemotherapy in patients with estrogen receptor (ER)-positive breast cancer remain unclear. The use of tumor grade, Ki-67, or ER expression failed to provide an accurate prognosis of the risk of relapse after surgery in patients. This study aimed to evaluate...

Descripción completa

Detalles Bibliográficos
Autores principales: Tsukamoto, Fumine, Arihiro, Koji, Takahashi, Mina, Ito, Ken-ichi, Ohsumi, Shozo, Takashima, Seiki, Oba, Takaaki, Yoshida, Masayuki, Kishi, Kazuki, Yamagishi, Keisuke, Kinoshita, Takayuki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8493674/
https://www.ncbi.nlm.nih.gov/pubmed/34610807
http://dx.doi.org/10.1186/s12885-021-08778-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8493674/
https://www.ncbi.nlm.nih.gov/pubmed/34610807
http://dx.doi.org/10.1186/s12885-021-08778-5

Ejemplares similares